Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
Status:
RECRUITING
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This study is being done to compare how well Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging may improve the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.
Phase:
PHASE2
Details
Lead Sponsor:
Clinton Bahler
Collaborators:
Indiana University Melvin and Bren Simon Cancer Center On Target Laboratories, LLC